Pfizer Inc (PFE)

$23.88 -0.20 (-0.83%)
Market Cap 138.90B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 7.94
Forward PE 8.13
Profit Margin 12.42%
Debt to Equity Ratio 0.71
Volume 49,385,200
Avg Vol 40,900,262
Day's Range N/A - N/A
Shares Out 5.70B
Stochastic %K 17%
Beta 0.34
Analysts Sell
Price Target $29.20

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
Micheal_Pothead
Micheal_Pothead Jul. 2 at 12:43 AM
$PFE I agree 😘
0 · Reply
Mike22332233
Mike22332233 Jul. 1 at 11:03 PM
$SLS UPDATED ... I said the following one month ago when SLS was $8-$9 about it going to $18-$22 after 80th event ... and people laughed ... I don't hear from them anymore !!! ... Timeline/Price Prediction: ... SLS will jump to $18-$22 after 80th event ... and then RUN UP TO $55-$60 on GROUNDBREAKING readout results 2 weeks later !!! ... from there, it will drift up to the $75-$80 area over the next month ... and soon after, the opening BO Offer will be place at about $140-$160 ... After, a possible 5 way Bidding War -- between $MRK, $ABBV, $BMY, $PFE, and RHHBY -- the FINAL BO PRICE will be reached at $202 in Q4 of 2026 !!! ... LIKE & FOLLOW me 👉 @Mike22332233 for SLS insight you will find nowhere else
2 · Reply
EmbraceVolatility
EmbraceVolatility Jul. 1 at 9:44 PM
$PFE bastard's trying to bring it down as low as possible before ex-dividend.
0 · Reply
ResearchTrends09
ResearchTrends09 Jul. 1 at 9:42 PM
$PFE
0 · Reply
jakeguess
jakeguess Jul. 1 at 9:28 PM
$PFE board is so much better with out Michael.
0 · Reply
ResearchTrends09
ResearchTrends09 Jul. 1 at 9:22 PM
$PFE 🛑🛑🛑🛑🛑read!!!!!!!
0 · Reply
Find_the_Cure
Find_the_Cure Jul. 1 at 9:03 PM
$PFE 💩💩💩🤣
0 · Reply
MrPeanutEsquire
MrPeanutEsquire Jul. 1 at 8:52 PM
$PFE The dividend isn't budging, Its really just a question of how crazy the market wants our yield to get before enough is enough
0 · Reply
jrh34
jrh34 Jul. 1 at 8:31 PM
$PFE To much bearishness plus a 7% dividend, I'm happy to take the opposing trade and collect money to wait.
1 · Reply
MrPeanutEsquire
MrPeanutEsquire Jul. 1 at 8:02 PM
$PFE Day 1 of living in regret
1 · Reply
Latest News on PFE
Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.

Jun 29, 2026, 4:43 PM EDT - 2 days ago

Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.

ABT ADM APD BAC CMCSA CVS DIS

Pfizer, Innovent GLP-1 drugs pass China insurance preliminary review

Jun 29, 2026, 1:20 AM EDT - 2 days ago

Pfizer, Innovent GLP-1 drugs pass China insurance preliminary review

Pfizer Declares Third-Quarter 2026 Dividend

Jun 24, 2026, 3:52 PM EDT - 7 days ago

Pfizer Declares Third-Quarter 2026 Dividend

Pfizer confirms FDA approval of Ibrance for HR+ metastatic breast cancer

2026-06-24T18:20:21.000Z - 7 days ago

Pfizer confirms FDA approval of Ibrance for HR+ metastatic breast cancer

FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance

Jun 24, 2026, 2:10 PM EDT - 7 days ago

FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance

FDA approves Pfizer’s Ibrance combo for metastatic breast cancer

2026-06-24T15:25:12.000Z - 7 days ago

FDA approves Pfizer’s Ibrance combo for metastatic breast cancer

Pfizer dismissed from US states' drug price-fixing lawsuit

Jun 24, 2026, 10:51 AM EDT - 7 days ago

Pfizer dismissed from US states' drug price-fixing lawsuit

China outpacing Europe in drug innovation and development, Pfizer executive says

Jun 23, 2026, 12:10 PM EDT - 8 days ago

China outpacing Europe in drug innovation and development, Pfizer executive says

Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts

Jun 23, 2026, 10:00 AM EDT - 8 days ago

Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts

Pfizer's experimental drug misses main goal of lung cancer trial

Jun 22, 2026, 4:43 PM EDT - 9 days ago

Pfizer's experimental drug misses main goal of lung cancer trial

Pfizer says sigvotatug vedotin did not show big improvement in primary endpoint

2026-06-22T20:33:17.000Z - 9 days ago

Pfizer says sigvotatug vedotin did not show big improvement in primary endpoint

Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

Jun 22, 2026, 4:30 PM EDT - 9 days ago

Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

Wall Street loves growth stocks — but these 10 ‘losers' are primed to win

Jun 22, 2026, 2:32 PM EDT - 9 days ago

Wall Street loves growth stocks — but these 10 ‘losers' are primed to win

ACHR AGCO COF DHI DVN EOG TSN

Pfizer (PFE) Shares Sink After Surprise CFO Exit

2026-06-18T18:35:11.000Z - 13 days ago

Pfizer (PFE) Shares Sink After Surprise CFO Exit

Pfizer reaffirms all components of FY26 guidance

2026-06-18T17:30:31.000Z - 13 days ago

Pfizer reaffirms all components of FY26 guidance

Pfizer CFO Dave Denton to step down, Cecile Guegan named interim CFO

2026-06-18T10:52:33.000Z - 13 days ago

Pfizer CFO Dave Denton to step down, Cecile Guegan named interim CFO

Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:52 AM EDT - 13 days ago

Pfizer CFO Dave Denton to step down, leave company in August

Pfizer Announces Chief Financial Officer Transition

Jun 18, 2026, 6:45 AM EDT - 13 days ago

Pfizer Announces Chief Financial Officer Transition

Pfizer CEO warns German investment at risk over drug pricing policies

Jun 10, 2026, 7:56 AM EDT - 21 days ago

Pfizer CEO warns German investment at risk over drug pricing policies

Want to Avoid the Whipsawing Tech Stocks? Dollar General and 7 Others to Buy.

Jun 9, 2026, 2:07 PM EDT - 22 days ago

Want to Avoid the Whipsawing Tech Stocks? Dollar General and 7 Others to Buy.

DG ALGN BBY BIIB CVS VZ

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

Jun 9, 2026, 9:20 AM EDT - 22 days ago

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

AMGN JNJ LLY MRK NVO

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

Jun 9, 2026, 3:20 AM EDT - 22 days ago

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

BMY LLY MRK RDW UTHR XBI

Pfizer Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 8, 2026, 8:00 AM EDT - 23 days ago

Pfizer Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:49 AM EDT - 23 days ago

US FDA approves Pfizer's bleeding disorder drug for children

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

Jun 8, 2026, 6:45 AM EDT - 23 days ago

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 25 days ago

Pfizer Transcript: Study update

Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 25 days ago

Pfizer Slides: Study update

Pfizer Press release: Study update

Jun 6, 2026, 11:00 AM EDT - 25 days ago

Pfizer Press release: Study update

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Jun 6, 2026, 9:06 AM EDT - 25 days ago

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide

Jun 6, 2026, 9:00 AM EDT - 25 days ago

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide

Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI

Jun 4, 2026, 10:00 AM EDT - 27 days ago

Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI

Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup

Jun 4, 2026, 6:40 AM EDT - 27 days ago

Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup

LLY

Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 2:00 PM EDT - 4 weeks ago

Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Jun 1, 2026, 10:00 AM EDT - 4 weeks ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

May 31, 2026, 8:00 AM EDT - 4 weeks ago

Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

Mailbag: A Follow-Up on Pfizer & Other Questions

May 30, 2026, 9:22 AM EDT - 4 weeks ago

Mailbag: A Follow-Up on Pfizer & Other Questions

AGNC LAND NLY PFFA

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

May 30, 2026, 8:00 AM EDT - 4 weeks ago

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

Seven-Year Analysis from Pfizer's LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer

May 29, 2026, 8:00 AM EDT - 4 weeks ago

Seven-Year Analysis from Pfizer's LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer

Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

May 28, 2026, 11:10 PM EDT - 4 weeks ago

Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

China's Innovent Biologics, Pfizer strike up to $10.5 billion cancer drug deal

May 28, 2026, 7:19 PM EDT - 4 weeks ago

China's Innovent Biologics, Pfizer strike up to $10.5 billion cancer drug deal

Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 28, 2026, 7:00 PM EDT - 4 weeks ago

Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 28, 2026, 7:00 PM EDT - 4 weeks ago

Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

May 27, 2026, 10:00 AM EDT - 5 weeks ago

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

Sarah Cannon Research Institute Announces Strategic Oncology Research Collaboration with Pfizer

May 20, 2026, 9:00 AM EDT - 6 weeks ago

Sarah Cannon Research Institute Announces Strategic Oncology Research Collaboration with Pfizer

Pfizer's pneumococcal shot shows stronger immune response in mid-stage trial

May 20, 2026, 5:08 AM EDT - 6 weeks ago

Pfizer's pneumococcal shot shows stronger immune response in mid-stage trial

Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results

May 20, 2026, 5:05 AM EDT - 6 weeks ago

Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results

Astellas to Present Data on Long-Term Outcomes and Clinical Use of Its Portfolio Across Disease Stages at ASCO 2026

May 18, 2026, 8:00 AM EDT - 6 weeks ago

Astellas to Present Data on Long-Term Outcomes and Clinical Use of Its Portfolio Across Disease Stages at ASCO 2026

Quest Diagnostics, Altria, and 12 More Stocks That Are Coming Back to Life After a Rough Patch

May 14, 2026, 2:22 PM EDT - 6 weeks ago

Quest Diagnostics, Altria, and 12 More Stocks That Are Coming Back to Life After a Rough Patch

DGX MO CL

European Commission Approves Pfizer's HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors

May 13, 2026, 6:45 AM EDT - 7 weeks ago

European Commission Approves Pfizer's HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors

Rigel strikes licensing deal for Pfizer and Arvinas' breast cancer drug

May 12, 2026, 8:00 AM EDT - 7 weeks ago

Rigel strikes licensing deal for Pfizer and Arvinas' breast cancer drug

ARVN RIGL

Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)

May 12, 2026, 7:00 AM EDT - 7 weeks ago

Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)

ARVN

Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC

May 5, 2026, 4:09 PM EDT - 2 months ago

Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC

Pfizer CEO on AI-designed molecule, and race to use new tech

May 5, 2026, 4:02 PM EDT - 2 months ago

Pfizer CEO on AI-designed molecule, and race to use new tech

3 Dividend Stocks for May 2026

May 5, 2026, 11:30 AM EDT - 2 months ago

3 Dividend Stocks for May 2026

SYY WSO

Pfizer Earnings Call Transcript: Q1 2026

May 5, 2026, 10:00 AM EDT - 2 months ago

Pfizer Earnings Call Transcript: Q1 2026

Pfizer Earnings release: Q1 2026

May 5, 2026, 10:00 AM EDT - 2 months ago

Pfizer Earnings release: Q1 2026

Pfizer Quarterly report: Q1 2026

May 5, 2026, 10:00 AM EDT - 2 months ago

Pfizer Quarterly report: Q1 2026

Pfizer Slides: Q1 2026

May 5, 2026, 10:00 AM EDT - 2 months ago

Pfizer Slides: Q1 2026

Pfizer Posts Better-Than-Expected Revenue, Profit

May 5, 2026, 8:35 AM EDT - 2 months ago

Pfizer Posts Better-Than-Expected Revenue, Profit

Pfizer Revenue Rises But Profit Falls Amid Boosted R&D Spending

May 5, 2026, 7:23 AM EDT - 2 months ago

Pfizer Revenue Rises But Profit Falls Amid Boosted R&D Spending

Pfizer Stock Edges Higher as Earnings and Revenue Beat Estimates

May 5, 2026, 7:06 AM EDT - 2 months ago

Pfizer Stock Edges Higher as Earnings and Revenue Beat Estimates

Why selling these 3 dividend stocks could be a mistake

May 5, 2026, 7:05 AM EDT - 2 months ago

Why selling these 3 dividend stocks could be a mistake

EPD UPS

Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth

May 5, 2026, 6:55 AM EDT - 2 months ago

Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth

Pfizer beats first-quarter profit estimates on strong demand for blood thinner Eliquis

May 5, 2026, 6:51 AM EDT - 2 months ago

Pfizer beats first-quarter profit estimates on strong demand for blood thinner Eliquis

Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance

May 5, 2026, 6:45 AM EDT - 2 months ago

Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance

Micheal_Pothead
Micheal_Pothead Jul. 2 at 12:43 AM
$PFE I agree 😘
0 · Reply
Mike22332233
Mike22332233 Jul. 1 at 11:03 PM
$SLS UPDATED ... I said the following one month ago when SLS was $8-$9 about it going to $18-$22 after 80th event ... and people laughed ... I don't hear from them anymore !!! ... Timeline/Price Prediction: ... SLS will jump to $18-$22 after 80th event ... and then RUN UP TO $55-$60 on GROUNDBREAKING readout results 2 weeks later !!! ... from there, it will drift up to the $75-$80 area over the next month ... and soon after, the opening BO Offer will be place at about $140-$160 ... After, a possible 5 way Bidding War -- between $MRK, $ABBV, $BMY, $PFE, and RHHBY -- the FINAL BO PRICE will be reached at $202 in Q4 of 2026 !!! ... LIKE & FOLLOW me 👉 @Mike22332233 for SLS insight you will find nowhere else
2 · Reply
EmbraceVolatility
EmbraceVolatility Jul. 1 at 9:44 PM
$PFE bastard's trying to bring it down as low as possible before ex-dividend.
0 · Reply
ResearchTrends09
ResearchTrends09 Jul. 1 at 9:42 PM
$PFE
0 · Reply
jakeguess
jakeguess Jul. 1 at 9:28 PM
$PFE board is so much better with out Michael.
0 · Reply
ResearchTrends09
ResearchTrends09 Jul. 1 at 9:22 PM
$PFE 🛑🛑🛑🛑🛑read!!!!!!!
0 · Reply
Find_the_Cure
Find_the_Cure Jul. 1 at 9:03 PM
$PFE 💩💩💩🤣
0 · Reply
MrPeanutEsquire
MrPeanutEsquire Jul. 1 at 8:52 PM
$PFE The dividend isn't budging, Its really just a question of how crazy the market wants our yield to get before enough is enough
0 · Reply
jrh34
jrh34 Jul. 1 at 8:31 PM
$PFE To much bearishness plus a 7% dividend, I'm happy to take the opposing trade and collect money to wait.
1 · Reply
MrPeanutEsquire
MrPeanutEsquire Jul. 1 at 8:02 PM
$PFE Day 1 of living in regret
1 · Reply
Maneee
Maneee Jul. 1 at 7:45 PM
$PFE shameless
0 · Reply
ArsenalFC23
ArsenalFC23 Jul. 1 at 7:35 PM
Sold my $BAYRY shares for a 35% profit. Took my money to build a starter position in $PFE with 1,2k shares @23,75. This will trade above 30+ next year when the Seagen drugs will be pushed to market. Until then lean back and collect the 7% divys.
0 · Reply
pasuny
pasuny Jul. 1 at 7:23 PM
$PFE Fire the fucking CEO!!!!!!
0 · Reply
jakeguess
jakeguess Jul. 1 at 7:15 PM
$PFE I am the largest shareholder of this chat so i decided to remove you
1 · Reply
nimii
nimii Jul. 1 at 7:14 PM
$PFE
0 · Reply
Micheal_Pothead
Micheal_Pothead Jul. 1 at 7:13 PM
$PFE who’s this guy
0 · Reply
jakeguess
jakeguess Jul. 1 at 7:13 PM
$PFE Quinn leads this chat now. Bye bye Michael
0 · Reply
jakeguess
jakeguess Jul. 1 at 7:12 PM
$PFE time for micheal to leave. Quinn kick this dude off he needs to leave
0 · Reply
Micheal_Pothead
Micheal_Pothead Jul. 1 at 7:10 PM
$PFE who’s this guy?
0 · Reply
Woodmont
Woodmont Jul. 1 at 6:55 PM
$PFE We need to get rid of the CEO and bring in a visionary, this guy has destroyed so much shareholder value
0 · Reply
simonds
simonds Jul. 1 at 6:37 PM
$PFE You are delusional
0 · Reply
Mike22332233
Mike22332233 Jul. 1 at 6:35 PM
$SLS DID YOU SEE MY STUNNING PREDICTION ... If the REGAL GPS trial comes in with my estimated HR of 0.27-0.33 (or lower), which would be AMAZINGLY GAME CHANGING ... We will get BO bids (and a bidding war) FROM EACH OF THE FOLLOWING: $MRK $BMY $PFE $ABBV RHHBY That's correct ... ALL 5 OF THEM!!! ... Like if you agree & FOLLOW ME @Mike22332233 for BO price
1 · Reply